Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure
European Heart Journal Open · 31.10.2025 · 5 (6)
DOI: 10.1093/ehjopen/oeaf157 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Heart Journal Open, online erschienen am 04.12.2025. Verfasst von Ganesh V Halade und 2 weiteren Autor:innen. Beteiligte Einrichtung: Heart Institute, Division of Cardiovascular Sciences, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 560 …. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institutes of Health.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Chronic unresolved inflammation is a major driver for the genesis of cardiovascular disease, originating from unhealthy lifestyle interactions with a network of metabolic genes impacting overall immune fitness. Acute inflammation is a host defence response overlapping with safe clearance of inflammation, termed as resolution of inflammation, co-ordinated by nutritionally originated fatty acid's interaction with immune-responsive enzymes. Especially processing of polyunsaturated fatty acids by immune-responsive lipoxygenase and cyclooxygenase orchestrates the biosynthesis of specialized proresolving mediators. In contrast, dysregulation due to an imbalanced lifestyle, such as an unhealthy diet, lack of sleep, and exercise/low physical activity, drives non-resolving inflammation. Overall, the quality of fatty acids, enzymatic processing, on-time biosynthesis of SPMs, and precise activation of SPM-specific receptors operate cardiac repair in heart failure with reduced ejection fraction; however, the dysfunction of specific receptors, such as FPR2, drives obesogenic ageing and heart failure with preserved ejection fraction. Thus, the overlapping inflammation–resolution signalling pathways that are essential for cardiac repair and the prevention of cardiac damage are highly relevant to cardiometabolic disorders and the subsequent development of heart failure. Therefore, future research is warranted to study lifestyle factors that maintain the balance of inflammation-resolution signalling in cardiac health and develop new therapeutic targets for resolution medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Institute, Division of Cardiovascular Sciences, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 560 Channelside Dr., Tampa, FL 33602, USA.
- Hypertension and Kidney Research Center, Heart Institute, University of South Florida, Tampa, FL 33602, USA.
- Department of Medicine, Solna, Karolinska Institutet, Stockholm 17176, Sweden.
- Department of Cardiology, Karolinska University Hospital, Stockholm 17176, Sweden.
- Université de Lorraine, Inserm, DCAC, Nancy 54000, France.
ORCID-Profile: Ganesh V Halade, Vasundhara Kain
Förderung
- National Institutes of Health
Zitieren
APA
Halade, G. V., Bäck, M., & Kain, V. (2025). Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure. European Heart Journal Open, 5(6). https://doi.org/10.1093/ehjopen/oeaf157
Vancouver
Halade GV, Bäck M, Kain V. Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure. European Heart Journal Open. 2025;5(6). doi:10.1093/ehjopen/oeaf157
BibTeX
@article{Halade2025,
author = {Halade, Ganesh V and Bäck, Magnus and Kain, Vasundhara},
title = {Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure},
journal = {European Heart Journal Open},
year = {2025},
volume = {5},
number = {6},
doi = {10.1093/ehjopen/oeaf157}
}
EUVIMED